These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8479130)
1. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Takemura T; Yoshioka K; Aya N; Murakami K; Matumoto A; Itakura H; Kodama T; Suzuki H; Maki S Kidney Int; 1993 Apr; 43(4):918-27. PubMed ID: 8479130 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250 [TBL] [Abstract][Full Text] [Related]
3. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Gröne HJ; Walli AK; Gröne E; Krämer A; Clemens MR; Seidel D Kidney Int; 1990 Jun; 37(6):1449-59. PubMed ID: 2163465 [TBL] [Abstract][Full Text] [Related]
4. Identification of oxidized low density lipoprotein in human renal biopsies. Lee HS; Kim YS Kidney Int; 1998 Sep; 54(3):848-56. PubMed ID: 9734609 [TBL] [Abstract][Full Text] [Related]
5. Distribution of type I collagen in human kidney diseases in comparison with type III collagen. Yoshioka K; Tohda M; Takemura T; Akano N; Matsubara K; Ooshima A; Maki S J Pathol; 1990 Oct; 162(2):141-8. PubMed ID: 2250192 [TBL] [Abstract][Full Text] [Related]
6. [Glomerular apolipoprotein B deposition in glomerular diseases]. Ohtani H; Matoba K; Saika Y; Tanaka R; Yamada Y; Bando K; Takahashi T; Mune M; Yukawa S; Nomoto H Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1145-52. PubMed ID: 2082049 [TBL] [Abstract][Full Text] [Related]
7. Significance of glomerular deposition of apolipoprotein (a) in various glomerulopathies. Suzuki S; Takahashi H; Sato H; Takashima N; Arakawa M; Gejyo F Am J Nephrol; 1997; 17(6):499-504. PubMed ID: 9426845 [TBL] [Abstract][Full Text] [Related]
8. Localization of apolipoprotein(a) and B-100 in various renal diseases. Sato H; Suzuki S; Ueno M; Shimada H; Karasawa R; Nishi S; Arakawa M Kidney Int; 1993 Feb; 43(2):430-5. PubMed ID: 8441239 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908 [TBL] [Abstract][Full Text] [Related]
10. Renal apolipoproteins in nephrotic rats. van Goor H; van der Horst ML; Atmosoerodjo J; Joles JA; van Tol A; Grond J Am J Pathol; 1993 Jun; 142(6):1804-12. PubMed ID: 8506949 [TBL] [Abstract][Full Text] [Related]
11. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity. Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963 [TBL] [Abstract][Full Text] [Related]
12. Alpha macroglobulins and the low-density-lipoprotein-related protein/alpha-2-macroglobulin receptor in experimental renal fibrosis. van Goor H; Diamond JR; Ding G; Kaysen G Exp Nephrol; 1999; 7(1):35-43. PubMed ID: 9892812 [TBL] [Abstract][Full Text] [Related]
13. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Yoshida H; Kondratenko N; Green S; Steinberg D; Quehenberger O Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):9-13. PubMed ID: 9693095 [TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms of lipid injury in the glomerulus. Schlondorff D Am J Kidney Dis; 1993 Jul; 22(1):72-82. PubMed ID: 8322798 [TBL] [Abstract][Full Text] [Related]
15. Interstitial foam cells and oxidized lipoprotein in human glomerular disease. Magil AB Mod Pathol; 1999 Jan; 12(1):33-40. PubMed ID: 9950160 [TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells. Quaschning T; Königer M; Krämer-Guth A; Greiber S; Pavenstädt H; Nauck M; Schollmeyer P; Wanner C Nephrol Dial Transplant; 1997 Dec; 12(12):2528-36. PubMed ID: 9430847 [TBL] [Abstract][Full Text] [Related]
17. A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Kerjaschki D; Ojha PP; Susani M; Horvat R; Binder S; Hovorka A; Hillemanns P; Pytela R Am J Pathol; 1989 Feb; 134(2):481-9. PubMed ID: 2521774 [TBL] [Abstract][Full Text] [Related]
18. Increased class A scavenger receptor and glomerular lipid precede mesangial matrix expansion in the bGH mouse model. Doi SQ; Chilakamarri GC; Mendonca MC; Araujo M; Nguyen N; Zuhl I; List EO; Kopchick JJ; Hirata MH; Sellitti DF Growth Horm IGF Res; 2010 Aug; 20(4):326-32. PubMed ID: 20576456 [TBL] [Abstract][Full Text] [Related]
19. [Expression of fibronectin receptor and vitronectin receptor in diseased human kidneys]. Okada M; Yoshioka K; Takemura T; Murakami K; Maki S Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1139-46. PubMed ID: 7505344 [TBL] [Abstract][Full Text] [Related]